Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
J05AB01	ACTI-VIR	G	Aciclovir - 200mg	200mg	Tablet, scored	1,039,238 L.L
J05AF10	AVIRAVIR	G	Entecavir monohydrate - 1mg	1mg	Tablet, film coated	32,224,230 L.L
J05AF10	APO-ENTECAVIR	G	Entecavir - 0.5mg	0.5mg	Tablet	28,943,287 L.L
J05AF10	AVIRAVIR	G	Entecavir monohydrate - 0.5mg	0.5mg	Tablet, film coated	32,224,230 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	40,075,575 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 500mg	500mg	Injectable concentrated powder for solution	78,813,513 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
L01BC01	ALEXAN	G	Cytarabine - 100mg/5ml	100mg/5ml	Injectable solution	388,370 L.L
L01BC01	ALEXAN	G	Cytarabine - 1,000mg/20ml	1,000mg/20ml	Injectable solution	2,848,946 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
L01BC07	AZACITIDINE NEAPOLIS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
L01BC07	AZACITIDINE SHILPA	G	Azacitidine - 100mg	100mg	Injectable powder	7,350,062 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for dispersion	17,850,751 L.L
L01EA01	APO-IMATINIB	G	Imatinib - 100mg	100mg	Tablet	18,838,684 L.L
L01EA02	APO-DASATINIB	G	Dasatinib - 70mg	70mg	Tablet	71,323,688 L.L
L01EA02	APO-DASATINIB	G	Dasatinib - 50mg	50mg	Tablet	71,323,688 L.L
L01EA02	APO-DASATINIB	G	Dasatinib - 20mg	20mg	Tablet	57,771,855 L.L
L01EB01	APO-GEFITINIB	G	Gefitinib - 250mg	250mg	Tablet	87,345,820 L.L
L01EB02	APO-ERLOTINIB	G	Erlotinib (HCl) - 100mg	100mg	Tablet	79,672,726 L.L
L01EB02	APO-ERLOTINIB	G	Erlotinib (HCl) - 150mg	150mg	Tablet	91,523,229 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	490,837,809 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	L.L
L01ED04	ALUNBRIG	B	Brigatinib - 30mg	30mg	Tablet, film coated	124,685,776 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 180mg	180mg	Tablet, film coated	493,595,998 L.L

...